For YOURLecturer Finance Paper
2015 Balance Sheet
| Period Ending | 12/31/15 | ||||||||||||
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash And Cash Equivalents | 2,459,000 | ||||||||||||
| Short Term Investments | 88,000 | ||||||||||||
| Net Receivables | 13,108,000 | Ratio | |||||||||||
| Inventory | 14,001,000 | ||||||||||||
| Other Current Assets | 722,000 | 2015 | 2014 | 2013 | |||||||||
| Total Current Assets | 30,378,000 | Current Ratio | 1.31 | ||||||||||
| Long Term Investments | - 0 | Debt / Equity Ratio | 1.52 | ||||||||||
| Property Plant and Equipment | 9,855,000 | Free Cash Flow | |||||||||||
| Goodwill | 38,106,000 | Earnings per Share | |||||||||||
| Intangible Assets | 13,878,000 | Price / earnings ratio | |||||||||||
| Accumulated Amortization | - 0 | Return on Equity | 14.1% | ||||||||||
| Other Assets | 1,440,000 | Net profit margin | |||||||||||
| Deferred Long Term Asset Charges | - | ||||||||||||
| Total Assets | 93,657,000 | ||||||||||||
| Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | ||||||||||
| Liabilities | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | |||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | 14,319,000 | ||||||||||||
| Short/Current Long Term Debt | 8,850,000 | ||||||||||||
| Other Current Liabilities | - 0 | ||||||||||||
| Total Current Liabilities | 23,169,000 | ||||||||||||
| Long Term Debt | 26,267,000 | ||||||||||||
| Other Liabilities | 1,542,000 | ||||||||||||
| Deferred Long Term Liability Charges | 5,437,000 | ||||||||||||
| Minority Interest | 7,000 | ||||||||||||
| Negative Goodwill | - | ||||||||||||
| Total Liabilities | 56,422,000 | ||||||||||||
| Stockholders' Equity | |||||||||||||
| Misc Stocks Options Warrants | 39,000 | ||||||||||||
| Redeemable Preferred Stock | - 0 | ||||||||||||
| Preferred Stock | - 0 | ||||||||||||
| Common Stock | 17,000 | ||||||||||||
| Retained Earnings | 35,506,000 | ||||||||||||
| Treasury Stock | (28,886,000) | ||||||||||||
| Capital Surplus | 30,948,000 | ||||||||||||
| Other Stockholder Equity | (389,000) | ||||||||||||
| Total Stockholder Equity | 37,235,000 | ||||||||||||
| Net Tangible Assets | (14,788,000) | ||||||||||||
| http://finance.yahoo.com/q/bs?s=CVS&annual |
Works Cited CVS Balance Sheet | CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
http://finance.yahoo.com/q/bs?s=CVS&annual2014 Balance Sheet
| Period Ending | 12/31/14 | ||||||||||||
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash And Cash Equivalents | 2,481,000 | ||||||||||||
| Short Term Investments | 34,000 | ||||||||||||
| Net Receivables | 10,672,000 | Ratio | |||||||||||
| Inventory | 11,930,000 | ||||||||||||
| Other Current Assets | 866,000 | 2015 | 2014 | 2013 | |||||||||
| Total Current Assets | 25,983,000 | Current Ratio | 1.37 | ||||||||||
| Long Term Investments | - 0 | Debt / Equity Ratio | 0.95 | ||||||||||
| Property Plant and Equipment | 8,843,000 | Free Cash Flow | |||||||||||
| Goodwill | 28,142,000 | Earnings per Share | |||||||||||
| Intangible Assets | 9,774,000 | Price / earnings ratio | |||||||||||
| Accumulated Amortization | - 0 | Return on Equity | 12.2% | ||||||||||
| Other Assets | 1,445,000 | Net profit margin | |||||||||||
| Deferred Long Term Asset Charges | - | ||||||||||||
| Total Assets | 74,187,000 | ||||||||||||
| Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | ||||||||||
| Liabilities | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | |||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | 12,363,000 | ||||||||||||
| Short/Current Long Term Debt | 6,664,000 | ||||||||||||
| Other Current Liabilities | - 0 | ||||||||||||
| Total Current Liabilities | 19,027,000 | ||||||||||||
| Long Term Debt | 11,630,000 | ||||||||||||
| Other Liabilities | 1,531,000 | ||||||||||||
| Deferred Long Term Liability Charges | 4,036,000 | ||||||||||||
| Minority Interest | 5,000 | ||||||||||||
| Negative Goodwill | - | ||||||||||||
| Total Liabilities | 36,229,000 | ||||||||||||
| Stockholders' Equity | |||||||||||||
| Misc Stocks Options Warrants | - 0 | ||||||||||||
| Redeemable Preferred Stock | - 0 | ||||||||||||
| Preferred Stock | - 0 | ||||||||||||
| Common Stock | 17,000 | ||||||||||||
| Retained Earnings | 31,849,000 | ||||||||||||
| Treasury Stock | (24,078,000) | ||||||||||||
| Capital Surplus | 30,418,000 | ||||||||||||
| Other Stockholder Equity | (248,000) | ||||||||||||
| Total Stockholder Equity | 37,958,000 | ||||||||||||
| Net Tangible Assets | 42,000 | ||||||||||||
| http://finance.yahoo.com/q/bs?s=CVS&annual |
Works Cited CVS Balance Sheet | CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
http://finance.yahoo.com/q/bs?s=CVS&annual2013 Balance Sheet
| Period Ending | 12/31/13 | ||||||||||||
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash And Cash Equivalents | 4,089,000 | ||||||||||||
| Short Term Investments | 88,000 | ||||||||||||
| Net Receivables | 9,631,000 | Ratio | |||||||||||
| Inventory | 11,045,000 | ||||||||||||
| Other Current Assets | 472,000 | 2015 | 2014 | 2013 | |||||||||
| Total Current Assets | 25,325,000 | Current Ratio | 1.64 | ||||||||||
| Long Term Investments | - 0 | Debt / Equity Ratio | 0.68 | ||||||||||
| Property Plant and Equipment | 8,615,000 | Free Cash Flow | |||||||||||
| Goodwill | 26,542,000 | Earnings per Share | |||||||||||
| Intangible Assets | 9,529,000 | Price / earnings ratio | |||||||||||
| Accumulated Amortization | - 0 | Return on Equity | 12.1% | ||||||||||
| Other Assets | 1,515,000 | Net profit margin | |||||||||||
| Deferred Long Term Asset Charges | - | ||||||||||||
| Total Assets | 71,526,000 | ||||||||||||
| Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | ||||||||||
| Liabilities | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | |||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | 10,316,000 | ||||||||||||
| Short/Current Long Term Debt | 5,109,000 | ||||||||||||
| Other Current Liabilities | - 0 | ||||||||||||
| Total Current Liabilities | 15,425,000 | ||||||||||||
| Long Term Debt | 5,109,000 | ||||||||||||
| Other Liabilities | 1,421,000 | ||||||||||||
| Deferred Long Term Liability Charges | 3,901,000 | ||||||||||||
| Minority Interest | |||||||||||||
| Negative Goodwill | - | ||||||||||||
| Total Liabilities | 25,856,000 | ||||||||||||
| Stockholders' Equity | |||||||||||||
| Misc Stocks Options Warrants | - 0 | ||||||||||||
| Redeemable Preferred Stock | - 0 | ||||||||||||
| Preferred Stock | - 0 | ||||||||||||
| Common Stock | 17,000 | ||||||||||||
| Retained Earnings | 28,493,000 | ||||||||||||
| Treasury Stock | (20,169,000) | ||||||||||||
| Capital Surplus | 29,777,000 | ||||||||||||
| Other Stockholder Equity | (180,000) | ||||||||||||
| Total Stockholder Equity | 37,938,000 | ||||||||||||
| Net Tangible Assets | 1,867,000 | ||||||||||||
| http://finance.yahoo.com/q/bs?s=CVS&annual |
Works Cited CVS Balance Sheet | CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
http://finance.yahoo.com/q/bs?s=CVS&annual2015 Income Statement
| Period Ending | 12/31/15 | ||||||||||
| Total Revenue | 153,290,000 | ||||||||||
| Cost of Revenue | 126,762,000 | ||||||||||
| Gross Profit | 26,528,000 | 2015 | 2014 | 2013 | |||||||
| Operating Expenses | Current Ratio | Ratio | |||||||||
| Research Development | - 0 | Debt / Equity Ratio | |||||||||
| Selling General and Administrative | - 0 | Free Cash Flow | |||||||||
| Non Recurring | - 0 | IS | Earnings per Share | 0.00 | |||||||
| Others | - 0 | IS | Price / earnings ratio | 20,554.66 | |||||||
| Return on Equity | |||||||||||
| Total Operating Expenses | - 0 | IS | Net profit margin | 3.4% | |||||||
| Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | ||||||||
| Operating Income or Loss | 9,454,000 | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | ||||||
| Income from Continuing Operations | |||||||||||
| Total Other Income/Expenses Net | 0 | ||||||||||
| Earnings Before Interest And Taxes | 9,454,000 | ||||||||||
| Interest Expense | 838,000 | ||||||||||
| Income Before Tax | 8,616,000 | ||||||||||
| Income Tax Expense | 3,386,000 | ||||||||||
| Minority Interest | (2,000) | ||||||||||
| Net Income From Continuing Ops | 5,230,000 | ||||||||||
| Non-recurring Events | |||||||||||
| Discontinued Operations | 9,000 | ||||||||||
| Extraordinary Items | 0 | ||||||||||
| Effect Of Accounting Changes | 0 | ||||||||||
| Other Items | 0 | ||||||||||
| Net Income | 5,237,000 | ||||||||||
| Preferred Stock And Other Adjustments | - | ||||||||||
| Net Income Applicable To Common Shares | 5,237,000 |
Works Cited: CVS Income Statement| CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
2014 Income Statement
| Period Ending | 12/31/14 | ||||||||||
| Total Revenue | 139,367,000 | Ratio | |||||||||
| Cost of Revenue | 114,000,000 | ||||||||||
| Gross Profit | 25,367,000 | 2015 | 2014 | 2013 | |||||||
| Operating Expenses | Current Ratio | ||||||||||
| Research Development | - 0 | Debt / Equity Ratio | |||||||||
| Selling General and Administrative | - 0 | Free Cash Flow | |||||||||
| Non Recurring | - 0 | IS | Earnings per Share | 0.00 | |||||||
| Others | - 0 | IS | Price / earnings ratio | 23,179.32 | |||||||
| Return on Equity | |||||||||||
| Total Operating Expenses | - 0 | IS | Net profit margin | 3.3% | |||||||
| Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | ||||||||
| Operating Income or Loss | 8,799,000 | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | ||||||
| Income from Continuing Operations | |||||||||||
| Total Other Income/Expenses Net | (521,000) | ||||||||||
| Earnings Before Interest And Taxes | 8,278,000 | ||||||||||
| Interest Expense | 600,000 | ||||||||||
| Income Before Tax | 7,678,000 | ||||||||||
| Income Tax Expense | 3,033,000 | ||||||||||
| Minority Interest | |||||||||||
| Net Income From Continuing Ops | 4,645,000 | ||||||||||
| Non-recurring Events | |||||||||||
| Discontinued Operations | (1,000) | ||||||||||
| Extraordinary Items | 0 | ||||||||||
| Effect Of Accounting Changes | 0 | ||||||||||
| Other Items | 0 | ||||||||||
| Net Income | 4,644,000 | ||||||||||
| Preferred Stock And Other Adjustments | - | ||||||||||
| Net Income Applicable To Common Shares | 4,644,000 |
Works Cited: CVS Income Statement| CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
2013 Income Statement
| Period Ending | 12/31/13 | ||||||||||
| Total Revenue | 126,761,000 | Ratio | |||||||||
| Cost of Revenue | 102,978,000 | ||||||||||
| Gross Profit | 23,783,000 | 2015 | 2014 | 2013 | |||||||
| Operating Expenses | Current Ratio | ||||||||||
| Research Development | - 0 | Debt / Equity Ratio | |||||||||
| Selling General and Administrative | - 0 | Free Cash Flow | |||||||||
| Non Recurring | - 0 | IS | Earnings per Share | 0.00 | |||||||
| Others | - 0 | IS | Price / earnings ratio | 23,441.81 | |||||||
| Return on Equity | |||||||||||
| Total Operating Expenses | - 0 | IS | Net profit margin | 3.6% | |||||||
| Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | ||||||||
| Operating Income or Loss | 8,037,000 | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | ||||||
| Income from Continuing Operations | |||||||||||
| Total Other Income/Expenses Net | 0 | ||||||||||
| Earnings Before Interest And Taxes | 8,037,000 | ||||||||||
| Interest Expense | 509,000 | ||||||||||
| Income Before Tax | 7,528,000 | ||||||||||
| Income Tax Expense | 2,928,000 | ||||||||||
| Minority Interest | |||||||||||
| Net Income From Continuing Ops | 4,600,000 | ||||||||||
| Non-recurring Events | |||||||||||
| Discontinued Operations | (8,000) | ||||||||||
| Extraordinary Items | 0 | ||||||||||
| Effect Of Accounting Changes | 0 | ||||||||||
| Other Items | 0 | ||||||||||
| Net Income | 4,592,000 | ||||||||||
| Preferred Stock And Other Adjustments | - | ||||||||||
| Net Income Applicable To Common Shares | 4,592,000 |
Works Cited: CVS Income Statement| CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
2015 Cash Flow
| Period Ending | 12/31/15 | ||||||||||
| Net Income | 5,237,000 | Ratio | |||||||||
| Operating Activities, Cash Flows Provided By or Used In | 2015 | 2014 | 2013 | ||||||||
| Depreciation | 2,092,000 | ||||||||||
| Adjustments To Net Income | (36,000) | Current Ratio | |||||||||
| Changes In Accounts Receivables | 1,594,000 | Debt / Equity Ratio | |||||||||
| Changes In Liabilities | 3,495,000 | Free Cash Flow | 15,533,000 | ||||||||
| Changes In Inventories | 1,141,000 | Earnings per Share | |||||||||
| Changes In Other Operating Activities | (357,000) | Price / earnings ratio | |||||||||
| Return on Equity | |||||||||||
| Total Cash Flow From Operating Activities | 13,166,000 | Net profit margin | |||||||||
| Investing Activities, Cash Flows Provided By or Used In | Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | |||||||
| Capital Expenditures | (2,367,000) | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | ||||||
| Investments | 387,000 | ||||||||||
| Other Cash flows from Investing Activities | (11,440,000) | ||||||||||
| Total Cash Flows From Investing Activities | (13,420,000) | ||||||||||
| Financing Activities, Cash Flows Provided By or Used In | |||||||||||
| Dividends Paid | (1,576,000) | ||||||||||
| Sale Purchase of Stock | (4,702,000) | ||||||||||
| Net Borrowings | 11,218,000 | ||||||||||
| Other Cash Flows from Financing Activities | (61,000) | ||||||||||
| Total Cash Flows From Financing Activities | 5,006,000 | ||||||||||
| Effect Of Exchange Rate Changes | (20,000.00) | ||||||||||
| Change In Cash and Cash Equivalents | (8,414,000) |
Works Cited CVS Cash Flow | CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
2014 Cash Flow
| Period Ending | 12/31/14 | ||||||||||
| Net Income | 4,644,000 | Ratio | |||||||||
| Operating Activities, Cash Flows Provided By or Used In | 2015 | 2014 | 2013 | ||||||||
| Depreciation | 1,931,000 | ||||||||||
| Adjustments To Net Income | (414,000) | Current Ratio | |||||||||
| Changes In Accounts Receivables | 737,000 | Debt / Equity Ratio | |||||||||
| Changes In Liabilities | 2,815,000 | Free Cash Flow | 12,993,000 | ||||||||
| Changes In Inventories | 770,000 | Earnings per Share | |||||||||
| Changes In Other Operating Activities | 374,000 | Price / earnings ratio | |||||||||
| Return on Equity | |||||||||||
| Total Cash Flow From Operating Activities | 10,857,000 | Net profit margin | |||||||||
| Investing Activities, Cash Flows Provided By or Used In | Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | |||||||
| Capital Expenditures | (2,136,000) | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | ||||||
| Investments | 519,000 | ||||||||||
| Other Cash flows from Investing Activities | (2,428,000) | ||||||||||
| Total Cash Flows From Investing Activities | (4,045,000) | ||||||||||
| Financing Activities, Cash Flows Provided By or Used In | |||||||||||
| Dividends Paid | (1,288,000) | ||||||||||
| Sale Purchase of Stock | (3,580,000) | ||||||||||
| Net Borrowings | (932,000) | ||||||||||
| Other Cash Flows from Financing Activities | |||||||||||
| Total Cash Flows From Financing Activities | (5,694,000) | ||||||||||
| Effect Of Exchange Rate Changes | (6,000.00) | ||||||||||
| Change In Cash and Cash Equivalents | (9,739,000) |
Works Cited CVS Cash Flow | CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
2013 Cash Flow
| Period Ending | 12/31/13 | ||||||||||
| Net Income | 4,592,000 | Ratio | |||||||||
| Operating Activities, Cash Flows Provided By or Used In | 2015 | 2014 | 2013 | ||||||||
| Depreciation | 1,870,000 | ||||||||||
| Adjustments To Net Income | 55,000 | Current Ratio | |||||||||
| Changes In Accounts Receivables | 2,210,000 | Debt / Equity Ratio | |||||||||
| Changes In Liabilities | 1,494,000 | Free Cash Flow | 7,631,000 | ||||||||
| Changes In Inventories | (12,000) | Earnings per Share | |||||||||
| Changes In Other Operating Activities | 30,000 | Price / earnings ratio | |||||||||
| Return on Equity | |||||||||||
| Total Cash Flow From Operating Activities | 5,647,000 | Net profit margin | |||||||||
| Investing Activities, Cash Flows Provided By or Used In | Shares Outstanding | 1,101,000,000 | 1,140,000,000 | 1,180,000,000 | |||||||
| Capital Expenditures | (1,984,000) | Closing Price Dec. 31 | 97.77 | 96.31 | 71.57 | ||||||
| Investments | 510,000 | ||||||||||
| Other Cash flows from Investing Activities | (361,000) | ||||||||||
| Total Cash Flows From Investing Activities | (1,835,000) | ||||||||||
| Financing Activities, Cash Flows Provided By or Used In | |||||||||||
| Dividends Paid | (1,097,000) | ||||||||||
| Sale Purchase of Stock | (3,476,000) | ||||||||||
| Net Borrowings | 3,274,000 | ||||||||||
| Other Cash Flows from Financing Activities | |||||||||||
| Total Cash Flows From Financing Activities | (1,237,000) | ||||||||||
| Effect Of Exchange Rate Changes | 3,000.00 | ||||||||||
| Change In Cash and Cash Equivalents | 2,714,000 |
Works Cited CVS Cash Flow | CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS
Stock Prices
| Prices | |
| Date | Adj Close* |
| 19-Feb-16 | 97.59 |
| 18-Feb-16 | 96.89 |
| 17-Feb-16 | 97.69 |
| 16-Feb-16 | 96.94 |
| 12-Feb-16 | 95.86 |
| 11-Feb-16 | 93.87 |
| 10-Feb-16 | 93.11 |
| Rate of Return | (4.59) |
Works Cited CVS Stock| CVS Health Corporation Common S Stock - Yahoo! Finance. (n.d.). Retrieved February 28, 2016, from http://finance.yahoo.com/q/bs?s=CVS